Cell Growth & Differentiation, Vol 4, Issue 12 1065-1070, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2

A Forus, VA Florenes, GM Maelandsmo, PS Meltzer, O Fodstad and O Myklebost
Department of Tumor Biology, Norwegian Radium Hospital, Montebello, Oslo.

Amplification of cellular oncogenes may be important for the development and progression of malignant tumors. In human sarcomas, amplification of several genes located to the q13-14 region of chromosome 12 has been reported. Because the mdm2 protein seems to inactivate the tumor suppressor protein p53, a selective growth advantage of 12q13-14 amplification has previously been assigned to increased copy number and expression of the MDM2 gene. We have analyzed a panel of 98 human sarcomas of different subtypes to characterize the 12q13-14 amplica and determine which of the genes GLI, A2MR, SAS, MDM2, and GADD153 (CHOP) in this region was most consistently amplified. MDM2 was amplified in 9 of the tumors, SAS in 10, GADD153 in 4, GLI in 2, and A2MR in 2. Amplification was, in most cases, associated with increased expression of the corresponding gene. SAS and MDM2 were coamplified in 8 of the tumors, whereas GADD153, GLI, and A2MR were only amplified together with SAS. One liposarcoma showed amplification of MDM2 alone, whereas two osteosarcomas and a rhabdomyosarcoma cell line showed amplification of SAS and GADD153 (CHOP) but not MDM2. It is suggested that the selective target for these amplica may be an as yet unidentified gene localized between SAS and MDM2.

This article has been cited by other articles:

				C. T. Miller, S. Aggarwal, T. K. Lin, S. L. Dagenais, J. I. Contreras, M. B. Orringer, T. W. Glover, D. G. Beer, and L. Lin Amplification and Overexpression of the Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 2 (DYRK2) Gene in Esophageal and Lung Adenocarcinomas Cancer Res., July 15, 2003; 63(14): 4136 - 4143. [Abstract] [Full Text] [PDF]

				S. Park and C. D. James Lanthionine Synthetase Components C-like 2 Increases Cellular Sensitivity to Adriamycin by Decreasing the Expression of P-Glycoprotein through a Transcription-mediated Mechanism Cancer Res., February 1, 2003; 63(3): 723 - 727. [Abstract] [Full Text] [PDF]

				J. W. Yoon, Y. Kita, D. J. Frank, R. R. Majewski, B. A. Konicek, M. A. Nobrega, H. Jacob, D. Walterhouse, and P. Iannaccone Gene Expression Profiling Leads to Identification of GLI1-binding Elements in Target Genes and a Role for Multiple Downstream Pathways in GLI1-induced Cell Transformation J. Biol. Chem., February 8, 2002; 277(7): 5548 - 5555. [Abstract] [Full Text] [PDF]

				T. Ueda, H. Sasaki, Y. Kuwahara, M. Nezu, T. Shibuya, H. Sakamoto, H. Ishii, K. Yanagihara, K.-i. Mafune, M. Makuuchi, et al. Deletion of the Carboxyl-Terminal Exons of K-sam/FGFR2 by Short Homology-mediated Recombination, Generating Preferential Expression ofSpecific Messenger RNAs Cancer Res., December 1, 1999; 59(24): 6080 - 6086. [Abstract] [Full Text] [PDF]

				S. N. Jones, A. R. Hancock, H. Vogel, L. A. Donehower, and A. Bradley Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis PNAS, December 22, 1998; 95(26): 15608 - 15612. [Abstract] [Full Text] [PDF]

				R. Godbout, M. Packer, and W. Bie Overexpression of a DEAD Box Protein (DDX1) in Neuroblastoma and Retinoblastoma Cell Lines J. Biol. Chem., August 14, 1998; 273(33): 21161 - 21168. [Abstract] [Full Text] [PDF]

				G. Teoh, M. Urashima, A. Ogata, D. Chauhan, J. A. DeCaprio, S. P. Treon, R. L. Schlossman, and K. C. Anderson MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells Blood, September 1, 1997; 90(5): 1982 - 1992. [Abstract] [Full Text] [PDF]